INDUSTRY
Ant Group and rivals race to commercialise AI healthcare in China
China's AI healthcare financing jumped from RMB 3.7 billion ($552 million) — after two years of stagnation — to RMB 13.9 billion ($2.07 billion) in 2026, drawing Ant Group, JD Health, Tencent, and iFlytek into direct competition.